p.77 抽出テキスト

24 References

1. Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2022;65:1925–1966. https://doi.org/10.1007/ s00125-022-05787-2 2. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022;183:109119. https://doi. org/10.1016/j.diabres.2021.109119 3. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract 2014;103:150–160. https://doi.org/10.1016/j.diabres. 2013.11.001 4. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–1334. https://doi.org/10.2337/dc09-9033 5. World Health Organization. Classification of Diabetes Mellitus 2019. Geneva, Switzerland, 1–36. 6. WHO Guidelines Approved by the Guidelines Review Committee. Use of glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva, Switzerland, 2011. 7. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2021;44(Suppl 1):S15–S33. https://doi.org/10.2337/dc21-S002 8. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5–S20. https://doi.org/10.2337/diacare.26.2007.s5 9. Pareek M, Bhatt DL, Nielsen ML, Jagannathan R, Eriksson K-F, Nilsson PM, et al. Enhanced predictive capability of a 1-hour oral glucose tolerance test: a prospective population-based cohort study. Diabetes Care 2018;41:171–177. https://doi.org/10. 2337/dc17-1351 10. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the US population in 1988– 2006. Diabetes Care 2010;33:562–568. https://doi.org/10.2337/dc09-1524 11. Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Diabetes Care 2018;41:2648–2668. https://doi.org/10.2337/ dci18-0052 12. Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World J Diabetes 2019;10:1–15. https://doi.org/10.4239/wjd.v10.i1.1 13. Holt RI, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2021;44:2589–2625. https://doi.org/10.2337/dci21-0043 14. Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA 2014;311:1225–1233. https://doi.org/10.1001/jama.2014.1873 15. Foteinopoulou E, Clarke CA, Pattenden RJ, Ritchie SA, McMurray EM, Reynolds RM, et al. Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetes. Diabet Med 2021;38:e14449. https://doi.org/10. 1111/dme.14449 16. Kietsiriroje N, Pearson S, Campbell M, Ariëns RA, Ajjan RA. Double diabetes: a distinct high-risk group? Diabetes Obes Metab 2019;21:2609–2618. https://doi.org/10.1111/ dom.13848 17. Riddle MC, Philipson LH, Rich SS, Carlsson A, Franks PW, Greeley SAW, et al. Monogenic diabetes: from genetic insights to population-based precision in care. Reflections from a diabetes care editors’ expert forum. Diabetes Care 2020;43: 3117–3128. https://doi.org/10.2337/dci20-0065 18. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012;97:16–38. https://doi.org/10.1210/jc.2011-2098 19. Bellis A, Mauro C, Barbato E, Ceriello A, Cittadini A, Morisco C. Stress-induced hyperglycaemia in non-diabetic patients with acute coronary syndrome: from molecular mechanisms to new therapeutic perspectives. Int J Mol Sci 2021;22:775. https://doi.org/10. 3390/ijms22020775 20. Norhammar A, Tenerz Å, Nilsson G, Hamsten A, Efendíc S, Rydén L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140–2144. https://doi. org/10.1016/S0140-6736(02)09089-X 21. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the Euro Heart Survey on diabetes and the heart. Eur Heart J 2004;25:1880–1890. https://doi.org/10.1016/j.ehj.2004.07.027 22. International Association of Diabetes Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–682. https://doi.org/10.2337/dc09-1848 23. Harreiter J, Fadl H, Kautzky-Willer A, Simmons D. Do women with diabetes need more intensive action for cardiovascular reduction than men with diabetes? Curr Diab Rep 2020;20:61. https://doi.org/10.1007/s11892-020-01348-2 24. Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ 2020;369:m1361. https://doi.org/10.1136/bmj.m1361 25. Lowe WL, Scholtens DM, Lowe LP, Kuang A, Nodzenski M, Talbot O, et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 2018;320:1005–1016. https://doi.org/10.1001/jama. 2018.11628 26. Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia 2019;62: 905–914. https://doi.org/10.1007/s00125-019-4840-2 27. Tobias DK, Stuart JJ, Li S, Chavarro J, Rimm EB, Rich-Edwards J, et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in a large prospective cohort of US women. JAMA Intern Med 2017;177:1735–1742. https://doi.org/ 10.1001/jamainternmed.2017.2790 28. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers 2019;5:47. https://doi.org/10.1038/s41572- 019-0098-8 29. Daly B, Toulis KA, Thomas N, Gokhale K, Martin J, Webber J, et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: a population-based cohort study. PLoS Med 2018;15:e1002488. https://doi. org/10.1371/journal.pmed.1002488 30. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, De Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am College Cardiol 2013;61:e78–e140. https://doi. org/10.1016/j.jacc.2012.11.019 31. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267–315. https:// doi.org/10.1093/eurheartj/ehv320 32. Zhou M, Liu J, Hao Y, Liu J, Huo Y, Smith SC, et al. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Cardiovasc Diabetol 2018;17:147. https://doi.org/10.1186/s12933-018-0793-x 33. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, et al. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation 2019;140: e294–e324. https://doi.org/10.1161/CIR.0000000000000691 34. Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, Mellbin L, et al. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology. Cardiovasc Diabetol 2015;14: 133. https://doi.org/10.1186/s12933-015-0296-y 35. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167: 1545–1551. https://doi.org/10.1001/archinte.167.14.1545 36. Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K, et al. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011;34:145–150. https://doi.org/10.2337/dc10-1206 37. Preiss D, Sattar N. Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. Lancet Diabetes Endocrinol 2016;4:555–556. https://doi.org/10.1016/S2213-8587(16)30097-3 38. Tabák AG, Brunner EJ, Lindbohm JV, Singh-Manoux A, Shipley MJ, Sattar N, et al. Risk of macrovascular and microvascular disease in diabetes diagnosed using oral glucose tolerance test with and without confirmation by hemoglobin A1c: the Whitehall II cohort study. Circulation 2022;146:995–1005. https://doi.org/10.1161/CIRCULATIONAHA. 122.059430 39. Mak K-H, Vidal-Petiot E, Young R, Sorbets E, Greenlaw N, Ford I, et al. Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. Eur J Prev Cardiol 2021;28:1795–1806. https://doi.org/10.1093/eurjpc/zwab011 40. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215–2222. https://doi. org/10.1016/S0140-6736(10)60484-9

ESC Guidelines                                                                                                                                                                                          4119

Downloaded from academic.oup.com/eurheartj/article/44/39/4043/7238227 by guest on 07 October 2026